Nuclear imaging evidence obtained by using [18F]AV-1451 tau PET and [11C]PiB amyloid PET demonstrated that cortical tau aggregation was greater in DLB or PDD patients in comparison with PD subjects without cognitive decline and normal controls [202]. This evidence concerns the gene MAPT and Parkinson disease.